The effect of regular physical activity (PA) on the microcirculatory functions and plasma antioxidant capacity in older athletes.
With its ex-Novartis cancer drug near the finish line, Adlai Nortye raises $97.5M in Nasdaq debut
The Nasdaq is welcoming another company hustling along a late-stage drug, with Adlai Nortye raising $97.5 million from an IPO and a concurrent private placement.